Cargando…
High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte
The induction of hypoxia tolerance has emerged as a novel therapeutic strategy for the treatment of ischemic diseases. The disruption of hypoxic signaling by hyperglycemia has been shown to contribute to diabetic cardiomyopathy. In this study, we explored the potential molecular mechanisms by which...
Autores principales: | Chen, Jian-Xiong, Li, Lanfang, Cantrell, Aubrey C., Williams, Quinesha A., Zeng, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093703/ https://www.ncbi.nlm.nih.gov/pubmed/37048134 http://dx.doi.org/10.3390/cells12071060 |
Ejemplares similares
-
TIGAR deficiency sensitizes angiotensin‐II‐induced renal fibrosis and glomerular injury
por: He, Xiaochen, et al.
Publicado: (2022) -
Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism
por: Li, Lanfang, et al.
Publicado: (2021) -
The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010) -
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
por: Hirota, Kiichi
Publicado: (2021) -
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
por: Xiong, Gaofeng, et al.
Publicado: (2018)